Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shionogi
Pharma
Takeda-Denali, Merck-Zhifei, Shionogi—Fierce Pharma Asia
Takeda ended its partnership with Denali. Merck and Zhifei adjusted their vaccine distribution deal. Shionogi won funding from the U.S. government.
Angus Liu
Apr 10, 2026 8:00am
Shionogi sets sights on US antibiotic plant with $119M from BARDA
Apr 8, 2026 2:14pm
Takeda, GLP-1 generics, Gilead—Fierce Pharma Asia
Mar 27, 2026 8:38am
Astellas, Takeda, Chugai and more—Fierce Pharma Asia
Jan 23, 2026 9:05am
Pfizer unleashes its stake in GSK's ViiV Healthcare for $1.9B
Jan 20, 2026 10:15am
China biotech deals, Shionogi's ALS buy—Fierce Pharma Asia
Jan 9, 2026 3:00am
